Nafamostat
ATC — · 1 markets · 17 records
JP 13 records · 4 shown of 4
- 50 mg per mL / per unit basis not statedinjectionナファモスタットメシル酸塩注射用100mg「NIG」ナファモスタットメシル酸塩注射用150mg「YD」、ナファモスタットメシル酸塩注用50mg「トーワ」、ナファモスタット注射用50mg「SW」、注射用フサン50
- 10 mg per mL / per unit basis not statedinjectionナファモスタットメシル酸塩注射用100mg「NIG」ナファモスタットメシル酸塩注射用150mg「YD」、ナファモスタットメシル酸塩注用50mg「トーワ」、ナファモスタット注射用50mg「SW」、注射用フサン10
- 100 mg per mL / per unit basis not statedinjectionナファモスタットメシル酸塩注射用100mg「NIG」ナファモスタットメシル酸塩注射用150mg「YD」
- 150 mg per mL / per unit basis not statedinjectionナファモスタットメシル酸塩注射用150mg「YD」
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.